Curbside Consult Volume 17, Issue 2 - Second Quarter 2019

Research Updates 

Assessment of Racial/Ethnic and Income Disparities in Opioid and Other Controlled Medication Prescriptions in California
Kyle Walburg, Pharm.D., Broadway Family Medicine
There is an association between race/ethnicity, income, and prevalence of controlled substance prescriptions - is there something pharmacists can do about it? 

Forming More Insight on Metformin
Haley Pals, Pharm.D., GuidePoint Pharmacy
Results from the 2002 Diabetes Prevention Program (DPP) showed metformin’s value as preventative therapy; will these effects stand the test of time in the 15-year follow-up, the Diabetes Prevention Program Outcomes Study (DPPOS)? 

Tobacco Cessation: E-cigarettes versus Nicotine Replacement Therapy
Jenna Gullickson, Pharm.D., CentraCare Health: St. Cloud
When providing tobacco cessation education, do your recommendations align with recent evidence? 

Therapeutic Thoughts

A Closer Look at the Increasing Cost of Insulin
Anne M. Schwartz, Pharm.D., Avera Marshall Regional Medical Center
Can anything be done to stop the increasing cost of insulin?

Best two-drug antihypertensive combinations for black African patients
Michelle Mages, Pharm.D., Hennepin Healthcare
Hypertension guidelines provide different direction on the best two-drug combinations for black patients. The CREOLE study investigates this conundrum by comparing three different two-drug combinations to find the best treatment for black patients.

From the Pharmacy Press  

A novel naloxone training compared with current recommended training in an overdose simulation
Tiffany Cheng, Pharm.D., Fairview Pharmacy Services
Naloxone is a potentially life saving drug during an opioid overdose. However, during an emergency situation, will we all be prepared to properly administer the reversal agent?  

Non-dihydropyridine Calcium Channel Blockers for the Treatment of Proteinuria
Ben Hierlmeier, Pharm.D., Park Nicollet
A recent literature review evaluated the utility of non-dihydropyridine calcium channel blockers for the treatment of proteinuria in diabetic and nondiabetic kidney disease. Where is their place in therapy?

Miscellaneous News  

Clinical Practice Guidelines: Sources We Can Trust?
Kristen Schroeder, Pharm.D., St. Cloud VA
Clinical practice guidelines are often the “go to” method when making pharmacological decisions, but should we be taking a deeper look?

FDA Approves First Generic Advair Diskus
Anjoli Punjabi, Pharm.D., MPH, Federally Qualified Urban Health Network
First generic Advair Diskus inhaler will likely improve patient access to inhaler therapy!

Digital ProAir Inhaler Available
Anjoli Punjabi, Pharm.D., MPH, Federally Qualified Urban Health Network
The first digital inhaler has arrived on the market providing a mechanism for providers to have increased patient respiratory data! 

New Drug Update

Esketamine (SPRAVATO™) – Janssen
Kristen Schroeder, Pharm.D., St. Cloud VA
The FDA recently approved SPRAVATO™, a treatment for treatment-resistant depression. What should practitioners know about this novel therapy?